A pilot study comparing Sentimag/Sienna versus standard modality for sentinel lymph node identification in patients with breast cancer

This publication has 9 references indexed in Scilit:

• Meta-analysis of sentinel lymph node biopsy in breast cancer using the magnetic technique
  British Journal of Surgery, 2016
• The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies
  Breast Cancer Research and Treatment, 2016
• The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment
  European Journal of Cancer Care, 2015
• Sentinel Node Biopsy Using a Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial
  Annals of Surgical Oncology, 2013
• Patient-Reported Outcomes in Sentinel Node–Negative Adjuvant Breast Cancer Patients Receiving Sentinel-Node Biopsy or Axillary Dissection: National Surgical Adjuvant Breast and Bowel Project Phase III Protocol B-32
  Journal of Clinical Oncology, 2010
• Adverse reactions to patent blue V dye – The NEW START and ALMANAC experience
  European Journal of Surgical Oncology, 2010
• Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial
  Annals of Surgical Oncology, 2010
• Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
  JNCI: Journal of the National Cancer Institute, 2006
• Sentinel Lymph Node Biopsy for Breast Cancer: A Suitable Alternative to Routine Axillary Dissection in Multi-Institutional Practice When Optimal Technique Is Used
  Journal of Clinical Oncology, 2000